Aviso Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.5M Sell
146,565
-3,175
-2% -$1.52M 2.56% 16
2026
Q1
$73.6M Buy
149,740
+2,699
+2% +$1.46M 2.61% 12
2025
Q4
$85.2M Buy
147,041
+31,555
+27% +$17.8M 3.24% 10
2025
Q3
$56M Buy
115,486
+3,607
+3% +$1.68M 2.28% 16
2025
Q2
$45.4M Buy
111,879
+9,287
+9% +$3.88M 2.05% 20
2025
Q1
$51M Buy
102,592
+7,483
+8% +$4.05M 2.52% 15
2024
Q4
$49.5M Buy
95,109
+3,236
+4% +$1.78M 2.5% 14
2024
Q3
$56.8M Buy
91,873
+977
+1% +$578K 2.82% 13
2024
Q2
$50.2M Buy
+90,896
New +$52.1M 2.8% 12

Other funds holding TMO

Aviso Financial's TMO Position: Q2 2026 in Review

Aviso Financial reduced its Thermo Fisher Scientific (TMO) stake by 2.1% in Q2 2026, selling an estimated $1.52M and leaving 146,565 shares worth $73.5M. The position accounts for 2.56% of the portfolio, ranked #16.

Aviso Financial first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $85.2M in Q4 2025. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Aviso Financial held 146,565 shares of Thermo Fisher Scientific worth $73.5M as of Q2 2026.
  • Aviso Financial sold 3,175 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.52M.
  • Thermo Fisher Scientific made up 2.56% of Aviso Financial's portfolio in Q2 2026, its #16 holding.
  • Aviso Financial first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Aviso Financial's Thermo Fisher Scientific position peaked at $85.2M in Q4 2025.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Aviso Financial's 13F filing for Q2 2026, filed 13 Aug 2026.